Literature DB >> 19679676

Quantitative evaluation of the expression and activity of five major sulfotransferases (SULTs) in human tissues: the SULT "pie".

Zoe Riches1, Emma L Stanley, Jackie C Bloomer, Michael W H Coughtrie.   

Abstract

Expression levels of the major human sulfotransferases (SULTs) involved in xenobiotic detoxification in a range of human tissues (i.e., SULT "pies") are not available in a form allowing comparison between tissues and individuals. Here we have determined, by quantitative immunoblotting, expression levels for the five principal human SULTs-SULT1A1, SULT1A3/4, SULT1B1, SULT1E1, and SULT2A1-and determined the kinetic properties toward probe substrates, where available, for these enzymes in cytosol samples from a bank of adult human liver, small intestine, kidney, and lung. We produced new isoform-selective antibodies against SULT1B1 and SULT2A1, which were used alongside antibodies against SULT1A3 and SULT1A1 previously produced in our laboratory or available commercially (SULT1E1). Expression levels were derived using purified recombinant enzymes to construct standard curves for each individual isoform and immunoblot. Substantial intertissue and interindividual differences in expression were observed. SULT1A1 was the major enzyme (>50% of total, range 420-4900 ng/mg cytosol protein) in the liver, followed by SULT2A1, SULT1B1, and SULT1E1. SULT1A3 was completely absent from this tissue. In contrast, the small intestine contained the largest overall amount of SULT of any of the tissues, with SULT1B1 the major enzyme (36%), closely followed by SULT1A3 (31%), and SULT1A1, SULT1E1, and SULT2A1 more minor forms (19, 8, and 6% of total, respectively). The kidney and lung contained low levels of SULT. We provide a unique data set that will add value to the study of the role and contribution of sulfation to drug and xenobiotic metabolism in humans.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19679676      PMCID: PMC2774979          DOI: 10.1124/dmd.109.028399

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  48 in total

Review 1.  Sulfotransferases in the bioactivation of xenobiotics.

Authors:  H Glatt
Journal:  Chem Biol Interact       Date:  2000-12-01       Impact factor: 5.192

2.  Expression profiling of human sulfotransferase and sulfatase gene superfamilies in epithelial tissues and cultured cells.

Authors:  T P Dooley; R Haldeman-Cahill; J Joiner; T W Wilborn
Journal:  Biochem Biophys Res Commun       Date:  2000-10-14       Impact factor: 3.575

3.  Sulfation of thyroid hormone and dopamine during human development: ontogeny of phenol sulfotransferases and arylsulfatase in liver, lung, and brain.

Authors:  K Richard; R Hume; E Kaptein; E L Stanley; T J Visser; M W Coughtrie
Journal:  J Clin Endocrinol Metab       Date:  2001-06       Impact factor: 5.958

Review 4.  Sulfonation and molecular action.

Authors:  Charles A Strott
Journal:  Endocr Rev       Date:  2002-10       Impact factor: 19.871

5.  Regulation of sulphotransferase expression in the endometrium during the menstrual cycle, by oral contraceptives and during early pregnancy.

Authors:  G L Rubin; A J Harrold; J A Mills; C N Falany; M W Coughtrie
Journal:  Mol Hum Reprod       Date:  1999-11       Impact factor: 4.025

6.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

Review 7.  Sulfation through the looking glass--recent advances in sulfotransferase research for the curious.

Authors:  M W H Coughtrie
Journal:  Pharmacogenomics J       Date:  2002       Impact factor: 3.550

8.  Human sulfotransferase SULT2A1 pharmacogenetics: genotype-to-phenotype studies.

Authors:  B A Thomae; B W Eckloff; R R Freimuth; E D Wieben; R M Weinshilboum
Journal:  Pharmacogenomics J       Date:  2002       Impact factor: 3.550

9.  Expression and characterization of the human 3 beta-hydroxysteroid sulfotransferases (SULT2B1a and SULT2B1b).

Authors:  C A Meloche; C N Falany
Journal:  J Steroid Biochem Mol Biol       Date:  2001-06       Impact factor: 4.292

10.  Human gastrointestinal sulfotransferases: identification and distribution.

Authors:  Guangping Chen; Daqing Zhang; Nin Jing; Shuhua Yin; Charles N Falany; Anna Radominska-Pandya
Journal:  Toxicol Appl Pharmacol       Date:  2003-03-15       Impact factor: 4.219

View more
  93 in total

Review 1.  Trends in oral drug bioavailability following bariatric surgery: examining the variable extent of impact on exposure of different drug classes.

Authors:  Adam S Darwich; Kathryn Henderson; Angela Burgin; Nicola Ward; Janet Whittam; Basil J Ammori; Darren M Ashcroft; Amin Rostami-Hodjegan
Journal:  Br J Clin Pharmacol       Date:  2012-11       Impact factor: 4.335

2.  Sulfation of ractopamine and salbutamol by the human cytosolic sulfotransferases.

Authors:  Kyounga Ko; Katsuhisa Kurogi; Garrett Davidson; Ming-Yih Liu; Yoichi Sakakibara; Masahito Suiko; Ming-Cheh Liu
Journal:  J Biochem       Date:  2012-07-04       Impact factor: 3.387

3.  To Apply Microdosing or Not? Recommendations to Single Out Compounds with Non-Linear Pharmacokinetics.

Authors:  Sieto Bosgra; Maria L H Vlaming; Wouter H J Vaes
Journal:  Clin Pharmacokinet       Date:  2016-01       Impact factor: 6.447

4.  Sulfation of hesperetin, naringenin and apigenin by the human cytosolic sulfotransferases: a comprehensive analysis.

Authors:  Amal A El Daibani; Yuecheng Xi; Lijun Luo; Xue Mei; Chunyang Zhou; Shin Yasuda; Ming-Cheh Liu
Journal:  Nat Prod Res       Date:  2018-11-06       Impact factor: 2.861

5.  A high frequency missense SULT1B1 allelic variant (L145V) selectively expressed in African descendants exhibits altered kinetic properties.

Authors:  Zachary E Tibbs; Amber L Guidry; Josie L Falany; Susan A Kadlubar; Charles N Falany
Journal:  Xenobiotica       Date:  2017-02-05       Impact factor: 1.908

6.  Investigating the substrate binding mechanism of sulfotransferase 2A1 based on substrate tunnel analysis: a molecular dynamics simulation study.

Authors:  Li Zhao; Pupu Zhang; Shiyang Long; Linlin Wang; Hanyong Jin; Weiwei Han; Pu Tian
Journal:  J Mol Model       Date:  2016-07-08       Impact factor: 1.810

7.  Endoxifen and other metabolites of tamoxifen inhibit human hydroxysteroid sulfotransferase 2A1 (hSULT2A1).

Authors:  Edwin J Squirewell; Xiaoyan Qin; Michael W Duffel
Journal:  Drug Metab Dispos       Date:  2014-08-25       Impact factor: 3.922

Review 8.  Structure, dynamics and selectivity in the sulfotransferase family.

Authors:  Thomas S Leyh; Ian Cook; Ting Wang
Journal:  Drug Metab Rev       Date:  2013-09-11       Impact factor: 4.518

9.  Tetrahydrobiopterin regulates monoamine neurotransmitter sulfonation.

Authors:  Ian Cook; Ting Wang; Thomas S Leyh
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-19       Impact factor: 11.205

10.  The gate that governs sulfotransferase selectivity.

Authors:  Ian Cook; Ting Wang; Steven C Almo; Jungwook Kim; Charles N Falany; Thomas S Leyh
Journal:  Biochemistry       Date:  2012-12-28       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.